Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
3
×
amgen
biotech
clinical trials
eli lilly
fda
life sciences
national
3
×
national blog main
national top stories
new york blog main
abbvie
biohaven
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
migraine
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
alder biopharmaceutical
american academy of neurology
anemia
antibiotic
What
fda
3
×
class
drugs
migraine
new
won
adults
allergan
approval
approved
arguments
august
big
bio
biotech
busy
commercialized
companies
competitors
days
decades
decisions
devices
drug
legacy
make
medicines
meeting
monday
neuro
news
nod
nods
opioid
oral
past
pill
potential
regulatory
roundup
Language
unset
Current search:
fda
×
national
×
allergan
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments